2023-508561-33-00招募中2 期
A phase I/II trial of TG4050, an individualised gene therapy, in patients with advanced cancer of the head and neck.
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- Transgene
- 入组人数
- 98
- 试验地点
- 13
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Julien Romanetto
Scientific
Transgene
研究点 (13)
Loading locations...
相似试验
招募中
1 期
A phase I of TG6050 in the treatment of patients with metastatic lung cancer2024-513093-22-00Transgene36
招募中
1 期
A Multicentre, Randomised Phase Ib Trial to evaluate Neoadjuvant Immunotherapy Combination of Nivolumab alone or plus Ipilimumab with the IL-2 Superkine MDNA11 alone or with Tocilizumab in Patients with High-Risk, Surgically Resectable Melanoma – NEO-CYT2024-519010-31-00Fondazione Melanoma Onlus80
招募中
1 期
A Phase 1 study of GSK5764227 in participants with advanced solid tumors2024-513663-10-01Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited112
招募中
2 期
A Phase 2a Trial to Investigate Safety, Tolerability and Exploratory Efficacy of AGP100 in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia2025-521611-39-00Agiana Pharmaceuticals AS10
已完成
1 期
A single-centre, open-label, phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers2024-515124-36-00Integrative Research Laboratories Sweden AB12